Pseudomyxoma peritonei

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Antimetabolite 1 substance
Alkylating agent 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Fondazione IRCCS Istituto Nazionale Dei Tumori Academic
    CAPECITABINE; CYCLOPHOSPHAMIDE MONOHYDRATE
    2024-514329-42-00 1 country 2024 n=31
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Fondazione IRCCS Istituto Nazionale Dei Tumori Academic 1 Phase II 1
New trials by year
2024
1
← All indication landscapes